• OPEN AN ACCOUNT
Indian Indices
Nifty
26,202.95 -12.60
(-0.05%)
Sensex
85,706.67 -13.71
( -0.02%)
Bank Nifty
59,752.70 15.40
( 0.03%)
Nifty IT
37,405.50 -40.80
( -0.11%)
Global Indices
Nasdaq
47,448.12 314.66
(0.67%)
Dow Jones
6,833.61 46.73
(0.69%)
Hang Seng
50,220.95 53.85
(0.11%)
Nikkei 225
9,688.31 -3.27
(-0.03%)
Forex
USD-INR
89.20 0.05
(0.06%)
EUR-INR
103.32 0.40
(0.39%)
GBP-INR
117.74 0.57
(0.49%)
JPY-INR
0.57 0.00
(0.07%)

EQUITY - MARKET SCREENER

Max Healthcare Institute Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
543220
INE027H01010
87.3624407
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MAXHEALTH
162.86
112921.19
EPS(TTM)
Face Value()
Div & Yield %
7.13
10
0.13
 

Abbott India Q2 PAT jumps 16% YoY to Rs 415 cr
Nov 06,2025

Profit before tax (PBT) stood at Rs 545.93 crore in Q2 FY26, up 13.87% year on year (YoY).

Total expenses increased 5.55% to Rs 1,281.17 crore in Q2 FY26 as against Rs 1,213.72 crore posted in same quarter last year. The cost of materials consumed stood at Rs 162.59 crore (down 5.50% YoY), employee benefit expense was at Rs 158.98 crore (up 7.85% YoY) and finance cost was at Rs 7.55 crore (up 202% YoY) during the period under review.

Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.

Shares of Abbott India rose 0.77% to settle at Rs 29,593.20 on the BSE.